FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
1-Year Est. Return
33.17%
1 Year Est. Return
+33.17%
AUM
$771M
AUM Growth
-$104M
(-12%)
Holding
45
Top Buys
| 1 | +$24.8M | |
| 2 | +$17.3M | |
| 3 | +$14.8M | |
| 4 |
CAI
Caris Life Sciences
CAI
|
+$11.2M |
| 5 |
Cidara Therapeutics
CDTX
|
+$8.8M |
Top Sells
| 1 | +$24.3M | |
| 2 | +$21.2M | |
| 3 | +$14.4M | |
| 4 |
Xenon Pharmaceuticals
XENE
|
+$13.8M |
| 5 |
Janux Therapeutics
JANX
|
+$11.8M |
Sector Composition
| 1 | Healthcare | 97.79% |
| 2 | Technology | 2.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
AnaptysBio
ANAB
$981M
| $78.6M | 10.19% |
3,539,593
-1,094,009
|
|
||
|
CNTA
2
Centessa Pharmaceuticals
CNTA
$3.24B
| $56.4M | 7.31% |
4,293,411
-580,713
|
|
||
|
PHLT
3
DELISTED
Performant Healthcare Inc
PHLT
| $52.7M | 6.83% |
13,170,381
+1,477,348
|
|
||
4
NeoGenomics
NEO
$1.38B
| $50M | 6.49% |
6,846,432
+803,610
|
|
||
5
Axogen
AXGN
$836M
| $49.1M | 6.37% |
4,529,243
+55,028
|
|
||
6
Health Catalyst
HCAT
$228M
| $46.1M | 5.98% |
12,230,181
+1,793,374
|
|
||
7
Twist Bioscience
TWST
$2.06B
| $34.8M | 4.51% |
945,033
-273,666
|
|
||
8
AtriCure
ATRC
$1.87B
| $33.3M | 4.31% |
1,015,170
-299,548
|
|
||
9
SI-BONE Inc
SIBN
$668M
| $33M | 4.27% |
1,751,001
+138,593
|
|
||
10
iRhythm Technologies
IRTC
$5.8B
| $28.8M | 3.74% |
187,355
-137,691
|
|
||
11
Crinetics Pharmaceuticals
CRNX
$3.86B
| $24.9M | 3.22% |
864,136
+8,717
|
|
||
12
Organogenesis Holdings
ORGO
$540M
| $24.8M | 3.22% |
+6,777,163
|
|
||
13
Edgewise Therapeutics
EWTX
$1.6B
| $22.5M | 2.91% |
1,714,019
-138,271
|
|
||
14
Ultragenyx Pharmaceutical
RARE
$3.23B
| $19.9M | 2.58% |
547,905
-84,128
|
|
||
15
Establishment Labs
ESTA
$1.42B
| $17.8M | 2.31% |
417,157
+80,287
|
|
||
16
ADMA Biologics
ADMA
$3.62B
| $17.3M | 2.25% |
+952,096
|
|
||
17
Senseonics Holdings
SENS
$286M
| $17M | 2.21% |
35,708,124
+31,050,619
|
|
||
18
KORU Medical Systems
KRMD
$196M
| $16.8M | 2.17% |
4,681,626
+226,700
|
|
||
19
Neuropace
NPCE
$347M
| $15.4M | 1.99% |
1,380,410
-203,638
|
|
||
20
Vera Therapeutics
VERA
$1.86B
| $13.3M | 1.72% |
562,981
-612,898
|
|
||
21
MiMedx Group
MDXG
$1B
| $11.8M | 1.53% |
1,927,494
-1,525,580
|
|
||
|
CAI
22
Caris Life Sciences
CAI
$8.74B
| $11.2M | 1.46% |
+443,043
|
|
||
23
Butterfly Network
BFLY
$561M
| $10.9M | 1.42% |
5,465,032
-40,617
|
|
||
|
24
Cidara Therapeutics
CDTX
$2.36B
| $8.8M | 1.14% |
+180,615
|
|
||
25
Evolent Health
EVH
$906M
| $8.32M | 1.08% |
738,550
+153,114
|
|